These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25867268)

  • 1. Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
    Matsubara A; Ogawa R; Suzuki H; Oda I; Taniguchi H; Kanai Y; Kushima R; Sekine S
    Br J Cancer; 2015 Apr; 112(8):1398-404. PubMed ID: 25867268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
    Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
    J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNAS-mutated carcinoma arising from gastric foveolar metaplasia in the duodenum after 9 years of observation.
    Matsuo Y; Yamamoto H; Sato Y; Oikawa R; Maehata T; Fujino T; Yahagi N; Yasuda H; Takagi M; Itoh F
    Clin J Gastroenterol; 2018 Oct; 11(5):391-395. PubMed ID: 29605945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent activating GNAS mutations in villous adenoma of the colorectum.
    Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
    J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
    Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
    Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.
    Sekine S; Ogawa R; Oshiro T; Kanemitsu Y; Taniguchi H; Kushima R; Kanai Y
    Genes Chromosomes Cancer; 2014 Apr; 53(4):366-72. PubMed ID: 24470207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
    Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.
    Hida R; Yamamoto H; Hirahashi M; Kumagai R; Nishiyama K; Gi T; Esaki M; Kitazono T; Oda Y
    Am J Surg Pathol; 2017 Mar; 41(3):343-353. PubMed ID: 27984236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
    Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
    Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach.
    Cho H; Hashimoto T; Naka T; Yatabe Y; Oda I; Saito Y; Yoshikawa T; Sekine S
    J Gastroenterol; 2022 May; 57(5):333-343. PubMed ID: 35188590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct.
    Tsai JH; Yuan RH; Chen YL; Liau JY; Jeng YM
    Am J Surg Pathol; 2013 Dec; 37(12):1862-70. PubMed ID: 24061513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
    Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
    PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.
    Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ
    Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
    Hashimoto T; Ogawa R; Matsubara A; Taniguchi H; Sugano K; Ushiama M; Yoshida T; Kanai Y; Sekine S
    Histopathology; 2015 Nov; 67(5):689-98. PubMed ID: 25832318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
    Wu J; Matthaei H; Maitra A; Dal Molin M; Wood LD; Eshleman JR; Goggins M; Canto MI; Schulick RD; Edil BH; Wolfgang CL; Klein AP; Diaz LA; Allen PJ; Schmidt CM; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B
    Sci Transl Med; 2011 Jul; 3(92):92ra66. PubMed ID: 21775669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
    Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M
    Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.